Academic Bibliography

Search 200 years of publications by Ghent University researchers.

prof. dr. Hans Van Vlierberghe

Work address: C. Heymanslaan 10
9000 Gent
Email: Hans.VanVlierberghe@UGent.be
ORCID iD: https://orcid.org/0000-0003-0647-9238

Show Sort by

Mark
- journalArticle
- open access
Quantification and isotopic analysis of bulk and of exchangeable and ultrafiltrable serum copper in healthy and alcoholic cirrhosis subjects

Sara Lauwens (UGent) , Marta Costas-Rodriguez, Joris Delanghe (UGent) , Hans Van Vlierberghe (UGent) and Frank Vanhaecke (UGent)

(2018) TALANTA. 189. p.332-338
Mark
- journalArticle
- open access
Ribavirin dose management in HCV patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirin

Jordan J. Feld, David E. Bernstein, Ziad Younes, Hans Van Vlierberghe (UGent) , Lois Larsen, Fernando Tatsch and Peter Ferenci

(2018) LIVER INTERNATIONAL. 38(9). p.1571-1575
Mark
- journalArticle
- open access
Hepatic Changes in the Fontan Circulation: Identification of Liver Dysfunction and an Attempt to Streamline Follow-up Screening

Thomas Ackerman (UGent) , Anja Geerts (UGent) , Hans Van Vlierberghe (UGent) , Julie De Backer (UGent) and Kato François (UGent)

(2018) Pediatric Cardiology.
Mark
Clinical burden of hepatitis E virus infection in a tertiary care center in Flanders, Belgium

Lien Cattoir (UGent) , FREDERIK VAN HOECKE (UGent) , Tom Van Maerken (UGent) , Eline Nys, Inge Ryckaert (UGent) , Matthias De Boulle, Anja Geerts (UGent) , Xavier Verhelst (UGent) , Isabelle Colle (UGent) , Veronik Hutse, et al.

(2018) JOURNAL OF CLINICAL VIROLOGY. 103. p.8-11
Mark
- journalArticle
- A1
- open access
The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma

Daniela Pollutri, Clarissa Patrizi, Sara Marinelli, Catia Giovannini, Elena Trombetta, Ferdinando A Giannone, Maurizio Baldassarre, Santina Quarta, Yves-Paul Vandewynckel, Astrid Vandierendonck (UGent) , et al.

(2018) CELL DEATH & DISEASE. 9.
Mark
- journalArticle
- A1
- open access
Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes

S Van Hees, S Bourgeois, Hans Van Vlierberghe (UGent) , T Sersté, S Francque, P Michielsen, D Sprengers, H Reynaert, J Henrion, S Negrin Dastis, et al.

(2018) ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 47(8). p.1170-1180
Mark
- journalArticle
- A1
- open access
Epidemiology, causes, evolution and outcome in a single-center cohort of 1116 critically ill patients with hypoxic hepatitis

Astrid Van den broecke, Laura Van Coile, Alexander Decruyenaere, Kirsten Colpaert (UGent) , Dominique Benoit (UGent) , Hans Van Vlierberghe (UGent) and Johan Decruyenaere (UGent)

(2018) ANNALS OF INTENSIVE CARE. 8.
Mark
Glycome patterns of perfusate in livers before transplantation associate with primary non-function

Xavier Verhelst (UGent) , Anja Geerts (UGent) , Ina Jochmans, Dieter Vanderschaeghe (UGent) , Agnes Paradissis (UGent) , Aude Vanlander (UGent) , Frederik Berrevoet (UGent) , Géraldine Dahlqvuist, Frederik Nevens, Jacques Pirenne, et al.

(2018) GASTROENTEROLOGY. 154(5). p.1361-1368
Mark
Placental growth factor inhibition targets pulmonary angiogenesis and represents a novel therapy for hepatopulmonary syndrome in mice

Sarah Raevens (UGent) , Anja Geerts (UGent) , Annelies Paridaens (UGent) , Sander Lefere (UGent) , Xavier Verhelst (UGent) , Anne Hoorens (UGent) , Jo Van Dorpe (UGent) , Tania Maes (UGent) , Ken Bracke (UGent) , Christophe Casteleyn (UGent) , et al.

(2018) HEPATOLOGY. 68(2). p.634-651
Mark
- conference
- C3
Early TIPS placement as a feasible and safe strategy for variceal bleeding in high risk liver patients : a 5-year monocentre experience

Ewout Verly, Xavier Verhelst (UGent) , Hans Van Vlierberghe (UGent) and Anja Geerts (UGent)

(2017) ACTA GASTRO-ENTEROLOGICA BELGICA. 80(1).

1
2
3
4
…
40
41

Next →